Sharfstein Leaving FDA: What Does It Mean? Consider The Source
This article was originally published in The Pink Sheet Daily
Executive Summary
The departure may help position the agency now that it faces a Republican majority in the House.
You may also be interested in...
Finally, An FDA Commissioner Who Tweets
The world is still adjusting to the advent of the Presidential tweet, but pharmaceutical manufacturers shouldn’t overlook another milestone of the social media era: an FDA commissioner who is active on Twitter.
FDA Oversight Among Hot Button Issues In 112th Congress
Health care reform and oversight of FDA remain hot button issues in the 112th Congress, industry advocates say.
FDA Oversight Among Hot Button Issues In 112th Congress
Health care reform and oversight of FDA remain hot button issues in the 112th Congress, industry advocates say.